Table 1.
Prognostic and predictive biomarkers commonly used in clinical practice
| Prognostic | Predictive | |
|---|---|---|
| Age |  | |
| CIRS | | |
| Stage | | |
| β2-microglobulin | |  |
| CD49d | | |
| CD38 | | |
| ZAP70 | | |
| IGHV mutation | | |
| 17p13 deletion | | |
| 11q22-23 deletion | | |
| Trisomy 12 | | |
| 13q14 deletion | | |
| TP53 mutation | | |
| SF3B1 mutation | | |
| NOTCH1 mutation | |  |
| Prognostic | Predictive | |
|---|---|---|
| Age | | |
| CIRS | | |
| Stage | | |
| β2-microglobulin | | |
| CD49d | | |
| CD38 | | |
| ZAP70 | | |
| IGHV mutation | | |
| 17p13 deletion | | |
| 11q22-23 deletion | | |
| Trisomy 12 | | |
| 13q14 deletion | | |
| TP53 mutation | | |
| SF3B1 mutation | | |
| NOTCH1 mutation | | |
A green circle indicates yes, a red circle indicates no, and an orange circle indicates not yet fully validated. CIRS, Cumulative Illness Rating Scale; IGHV, immunoglobulin heavy variable gene.